S20-183 mRNA Vaccines: Methods of Synthesis and Stability Assessment As part of a portfolio of COVID-19 inspired innovations, Stanford researchers led by Dr. Rhiju Das Eesha Sharma Maria Barna Kathrin Leppek Gun woo Byeon
S20-258 Chemical Additive Reduces Cost of Manufacturing mRNA Stanford researchers have discovered that ribonucleoside vanadyl complexes can be used as an additive in transcription reactions resulting in ~2-fold increased yield. Eesha Sharma Ivan Zheludev